American Portfolios Advisors Eagle Pharmaceuticals, Inc. Transaction History

American Portfolios Advisors

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Mar 24, 2023	BUY	$54.32 - $64.31 $16,296 - $19,293	300 New	300 $18 Million
Q2 2019 Mar 24, 2023	BUY	$46.61 - $58.45 $13,983 - $17,535	300 New	300 $16.7 Million
Q3 2018 Mar 24, 2023	BUY	$66.65 - $83.86 $19,995 - $25,158	300 New	300 $20.8 Million
Q1 2018 Mar 24, 2023	BUY	$52.16 - $66.86 $15,647 - $20,058	300 New	300 $15.8 Million
Q4 2017 Mar 24, 2023	BUY	$49.6 - $60.87 $14,880 - $18,261	300	300 $16 Million

8.6M

100

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $7.81M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

Get notified when there are updates to the investment portfolio of American Portfolios Advisors, based on Form 13F filings with the SEC.

Stay updated on American Portfolios Advisors with notifications on news.